# Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation Recipients

> **NCT04260828** · PHASE4 · UNKNOWN · sponsor: **Henan Provincial People's Hospital** · enrollment: 368 (estimated)

## Conditions studied

- Renal Transplant

## Interventions

- **DRUG:** Aspirin 100mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04260828
- **Lead sponsor:** Henan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-28
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 368 (ESTIMATED)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04260828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04260828, "Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04260828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*